叶酰多聚谷氨酸合成酶与甲氨蝶呤敏感性的关系  

Relationship between folypolyglutamate synthetase and methotrexate drug sensitivity

作　　者：胡椿艳（综述）[1] 岳丽杰[1] 陈小文（审校）[1] 

机构地区：[1]重庆医科大学深圳儿童医院儿研所,518026

出　　处：《国际儿科学杂志》2012年第2期183-186,共4页International Journal of Pediatrics

基　　金：国家自然科学基金资助项目（30471830）;深圳市科技计划项目（200802065）

摘　　要：叶酰多聚谷氨酸合成酶（folypolyglutamatesynthetase，FPGS）作为甲氨蝶呤（methotrexate，MTX）类抗肿瘤药物细胞内代谢过程中的关键酶，催化形成活性形式的MTX多聚谷氨酸，其异常是MTX耐药的重要原因之一。近年来研究发现，FPGS表达及活性的降低可使细胞内MTX多聚谷氨酸浓度降低，从而导致MTX耐药。FPGS基因多态性在MTX耐药中也起着重要的作用，但其具体机制尚未完全明了。该文就FPGS酶活性及基因多态性与MTX药物敏感性的关系进行综述。Folypolyglutamate synthetase（FPGS） catalyzes the addition of multiple glutamate molecules to compounds with the basic pteroylglutamate structure, such as polyglutamylation-dependent novel antifolates. As the antifolates like methotrexate require polyglutamation by FPGS for activation, FPGS has an established position in the cytotoxic action of methotrexate and has become a essential part in methotrexate resistance. Recent studies have indicated that decreased mRNA expression and activity of FPGS can cause reduction of methotrex- ate-polyglutamates accumulation,which have been observed as a dominant mechanism leading to methotrexate resistance. Furthermore, single nucleotide polymorphism in FPGS has been displayed significant associations with methotrexate sensitivity and susceptibility of deseases, though the detail mechanism is unknown. This paper is to review the relationshitip among FPGS enzvme activitv. gene polvmorohism and methotrexate drug sensitivity.

关 键 词：叶酰多聚谷氨酸合成酶 甲氨蝶呤 药物敏感性 

分 类 号：R692.502[医药卫生—泌尿科学]